Evans syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
* Considered a rare to very rare autoimmune disorder it has had few studies with cohorts often less than 30.{{fact|date=March 2015}} | |||
The incidence of Evan’s Syndrome is not precisely known. The syndrome is reported to be a complication affecting 4-10% of those individuals with a particular type of thrombocytopenia known as idiopathic thrombocytopenic purpura. | * The incidence of Evan’s Syndrome is not precisely known. The syndrome is reported to be a complication affecting 4-10% of those individuals with a particular type of thrombocytopenia known as idiopathic thrombocytopenic purpura. | ||
===Age=== | ===Age=== |
Revision as of 17:38, 10 January 2016
Evans syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Evans syndrome epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Evans syndrome epidemiology and demographics |
Risk calculators and risk factors for Evans syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
- Considered a rare to very rare autoimmune disorder it has had few studies with cohorts often less than 30.[citation needed]
- The incidence of Evan’s Syndrome is not precisely known. The syndrome is reported to be a complication affecting 4-10% of those individuals with a particular type of thrombocytopenia known as idiopathic thrombocytopenic purpura.
Age
The syndrome is more prevalent in children than in adults.